Effect of Laughter Therapy on Perceived Stress and Quality of Life
1 other identifier
interventional
42
1 country
1
Brief Summary
Breast cancer is the most common type of cancer seen in women worldwide and ranks first. Chemotherapy is one of the commonly used methods of treatment in breast cancer. Physiological and psychological symptoms that occur due to chemotherapy treatment affect women negatively and reduce their quality of life. For this reason, there is a need for an intervention that could decrease psychological symptoms such as stress and improve quality of life in women with breast cancer. In the literature, it is stated that laughter therapy which is one of the non-pharmacological methods, can be an effective nursing intervention to decrease stress and improve the quality of life in women with breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 17, 2022
CompletedFirst Submitted
Initial submission to the registry
May 21, 2022
CompletedFirst Posted
Study publicly available on registry
May 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2022
CompletedJune 30, 2022
June 1, 2022
3 months
May 21, 2022
June 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perceived Stress Scale
The scale consists of 14 items in total and was designed to measure how stressful the changing situations in the individual's life are perceived.The scale is a 5-point Likert-type scale with each item ranging from "never (0)" to "very often (4)". 7 of the scale items with positive expressions are scored in reverse and the total score that can be obtained from the scale ranges from 0 to 56. Eskin et al. performed the validity and reliability study of the Turkish version of Perceived Stress Scale and the internal consistency of the scale was determined to be 0.82.
The scale was filled in the baseline (before the beginning of the Laughter therapy), 5th and 9th weeks.
Secondary Outcomes (1)
Quality of Life Scale (SF-12)
The scale was filled in the baseline (before the beginning of the Laughter therapy), 5th and 9th weeks.
Study Arms (2)
Laughter Therapy Group
EXPERIMENTALThe women with breast cancer in the intervention group received two sessions of laughter therapy per week for eight weeks.Each laughter therapy session lasted 40 minutes.
Control group
NO INTERVENTIONThe control group did not receive any intervention during the study period.
Interventions
Each session started with a 10-minute breathing exercise accompanied by relaxing music, followed by 20-minute laughing exercises. Afterwards, the session was ended with a 10-minute meditation accompanied by relaxing music.
Eligibility Criteria
You may qualify if:
- years and older women,
- Stages II or III breast cancer
- Receiving Pacitaxel chemotherapy regimen per a week
You may not qualify if:
- Using any complementary and alternative (CAM) treatment method during practice
- Having psychological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir Bakircay University Health Sciences Faculty
Izmir, 35560, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asistant Professor
Study Record Dates
First Submitted
May 21, 2022
First Posted
May 25, 2022
Study Start
February 17, 2022
Primary Completion
May 31, 2022
Study Completion
June 12, 2022
Last Updated
June 30, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share